Jonathan E. Constance

772 total citations
35 papers, 575 citations indexed

About

Jonathan E. Constance is a scholar working on Pharmacology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jonathan E. Constance has authored 35 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Infectious Diseases and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jonathan E. Constance's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Jonathan E. Constance is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Jonathan E. Constance collaborates with scholars based in United States, Germany and Canada. Jonathan E. Constance's co-authors include Catherine M.T. Sherwin, Carol S. Lim, Michael G. Spigarelli, Chris Stockmann, Michael R. Franklin, Jessica K. Roberts, M. Denise Dearing, John G. Lamb, Alfred H. Balch and Shannon Haley and has published in prestigious journals such as Journal of Controlled Release, Pharmaceutical Research and Epilepsia.

In The Last Decade

Jonathan E. Constance

35 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan E. Constance United States	16	161	120	116	101	82	35	575
Sam Liao United States	14	80 0.5×	97 0.8×	58 0.5×	134 1.3×	42 0.5×	27	695
Mohammad Sharif Hossain United States	17	325 2.0×	159 1.3×	63 0.5×	181 1.8×	93 1.1×	63	930
Michael Krämer Germany	15	159 1.0×	59 0.5×	77 0.7×	120 1.2×	207 2.5×	49	860
Barbara W Adam United States	11	273 1.7×	96 0.8×	84 0.7×	95 0.9×	220 2.7×	16	988
Ni Zhu China	15	399 2.5×	41 0.3×	64 0.6×	52 0.5×	42 0.5×	65	781
Ana Acácia S. Pinheiro Brazil	21	333 2.1×	28 0.2×	130 1.1×	156 1.5×	62 0.8×	64	1.1k
Seok Hwee Koo Singapore	16	195 1.2×	49 0.4×	68 0.6×	173 1.7×	73 0.9×	49	702
Nopporn Apiwattanakul Thailand	13	114 0.7×	64 0.5×	151 1.3×	152 1.5×	241 2.9×	60	905
James DeVente United States	12	393 2.4×	117 1.0×	44 0.4×	140 1.4×	90 1.1×	40	951
Tri Hanggono Achmad Indonesia	14	161 1.0×	59 0.5×	321 2.8×	237 2.3×	83 1.0×	56	928

Countries citing papers authored by Jonathan E. Constance

Since Specialization

Citations

This map shows the geographic impact of Jonathan E. Constance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan E. Constance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan E. Constance more than expected).

Fields of papers citing papers by Jonathan E. Constance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan E. Constance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan E. Constance. The network helps show where Jonathan E. Constance may publish in the future.

Co-authorship network of co-authors of Jonathan E. Constance

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan E. Constance. A scholar is included among the top collaborators of Jonathan E. Constance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan E. Constance. Jonathan E. Constance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Constance, Jonathan E., Mary McFarland, Michael W. Deininger, et al.. (2023). Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review. JMIR Research Protocols. 12. e38167–e38167. 1 indexed citations

Rower, Joseph E., Diana G. Wilkins, Jacob Wilkes, et al.. (2020). Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer. Journal of Adolescent and Young Adult Oncology. 10(2). 175–184. 5 indexed citations

Constance, Jonathan E., David Reith, Robert M. Ward, et al.. (2017). Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin. Journal of Perinatology. 37(10). 1093–1102. 14 indexed citations

Job, Kathleen M., Jared Olson, Chris Stockmann, et al.. (2016). Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections. Expert Review of Anti-infective Therapy. 14(8). 731–746. 25 indexed citations

Job, Kathleen M., Tony K. L. Kiang, Jonathan E. Constance, Catherine M.T. Sherwin, & Elena Y. Enioutina. (2016). Herbal medicines: challenges in the modern world. Part 4. Canada and United States. Expert Review of Clinical Pharmacology. 9(12). 1597–1609. 31 indexed citations

Balch, Alfred H., Jonathan E. Constance, Michael G. Spigarelli, & Catherine M.T. Sherwin. (2015). A Retrospective Study of Kidney Injury vs Vancomycin Use by Age. Clinical Pharmacology in Drug Development. 4. 1–60. 1 indexed citations

Enioutina, Elena Y., Jonathan E. Constance, Chris Stockmann, et al.. (2015). Pharmacokinetic considerations in the use of antivirals in neonates. Expert Opinion on Drug Metabolism & Toxicology. 11(12). 1861–1878. 4 indexed citations

Grimsrud, Kristin, Catherine M.T. Sherwin, Jonathan E. Constance, et al.. (2015). Special population considerations and regulatory affairs for clinical research. Clinical Research and Regulatory Affairs. 32(2). 45–54. 38 indexed citations

Constance, Jonathan E., Alfred H. Balch, Catherine M.T. Sherwin, E. Kent Korgenski, & Michael G. Spigarelli. (2014). Evaluation of Disparities in Achieving TherapeuticRecommendations Among Pediatric Patients Receiving Gentamicin. Clinical Pharmacology in Drug Development. 3. 1–59. 3 indexed citations

10.

Stockmann, Chris, Jonathan E. Constance, Jessica K. Roberts, et al.. (2014). Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications. Clinical Pharmacokinetics. 53(5). 429–454. 38 indexed citations

11.

Constance, Jonathan E., Chris Stockmann, Sarah Campbell, et al.. (2014). Epidemiological Evaluation of Blood Culture Patterns among Neonates Receiving Vancomycin. Indian Journal of Microbiology. 54(4). 389–395. 2 indexed citations

12.

Roberts, Jessica K., Chris Stockmann, Jonathan E. Constance, et al.. (2014). Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants. Clinical Pharmacokinetics. 53(7). 581–610. 33 indexed citations

13.

Stockmann, Chris, Michael G. Spigarelli, Sarah Campbell, et al.. (2013). Considerations in the Pharmacologic Treatment and Prevention of Neonatal Sepsis. Pediatric Drugs. 16(1). 67–81. 26 indexed citations

14.

Constance, Jonathan E., et al.. (2012). Selective Targeting of c-Abl via a Cryptic Mitochondrial Targeting Signal Activated by Cellular Redox Status in Leukemic and Breast Cancer Cells. Pharmaceutical Research. 29(8). 2317–2328. 9 indexed citations

15.

Constance, Jonathan E., et al.. (2012). Enhanced and Selective Killing of Chronic Myelogenous Leukemia Cells with an Engineered BCR-ABL Binding Protein and Imatinib. Molecular Pharmaceutics. 9(11). 3318–3329. 10 indexed citations

16.

Dixon, Andrew S., Jonathan E. Constance, Tomoyuki Tanaka, Terence H. Rabbitts, & Carol S. Lim. (2011). Changing the Subcellular Location of the Oncoprotein Bcr-Abl Using Rationally Designed Capture Motifs. Pharmaceutical Research. 29(4). 1098–1109. 13 indexed citations

17.

Ali, Atif, et al.. (2011). A once‐per‐day, drug‐in‐food protocol for prolonged administration of antiepileptic drugs in animal models. Epilepsia. 53(1). 199–206. 15 indexed citations

18.

Dixon, Andrew S., et al.. (2009). Controlling subcellular localization to alter function: Sending oncogenic Bcr–Abl to the nucleus causes apoptosis. Journal of Controlled Release. 140(3). 245–249. 20 indexed citations

19.

Haley, Shannon, John G. Lamb, Michael R. Franklin, Jonathan E. Constance, & M. Denise Dearing. (2008). “Pharm‐Ecology” of Diet Shifting: Biotransformation of Plant Secondary Compounds in Creosote (Larrea tridentata) by a Woodrat Herbivore,Neotoma lepida. Physiological and Biochemical Zoology. 81(5). 584–593. 20 indexed citations

20.

Franklin, Michael R. & Jonathan E. Constance. (2007). Comparative 1-Substituted Imidazole Inhibition of Cytochrome P450 Isozyme-Selective Activities in Human and Mouse Hepatic Microsomes. Drug Metabolism Reviews. 39(2-3). 309–322. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact